Skip to main content
editorial
. 2015 Oct 1;6(3):470–474. doi: 10.1007/s13142-015-0345-9

Table 1.

Comparison of the five measurement systems

PROMIS® NIH Toolbox® Neuro-QoL ASCQ-Me PRO-CTCAE
Type of Measure Self-report, proxy-report Performance-based; self-report, proxy-report Self-report Self-report Self-report
Generic or Disease-Specific Generic Generic Neurological conditions Sickle Cell Disease Cancer
Constructs Measured Physical, mental, social, and global health domains Emotion, cognition, sensation, and motor function Effects of neurological conditions on physical, mental, and social health domains Effects of Sickle Cell Disease on physical, social, and emotional functioning and well-being Symptomatic toxicity (companion to CTCAE)
Available Instruments Item banks addressing >75 domains Item banks and performance-based measures of function organized into four domain batteries (emotion, cognition, sensation, and motor function) Item banks addressing >20 domains Item banks addressing >7 domains 124 items reflecting 78 symptomatic toxicities
Formats Static short forms, computerized adaptive tests (CATs) Static short forms, CATs Static short forms, CATs Static short forms, CATs Static short forms with conditional branching
Mode of Administration Paper, web, handheld device, interactive voice response system (IVRS) Paper (for emotion), web, handheld device (for all) Paper, web, handheld device, IVRS Paper, web, handheld device, IVRS Paper, web, IVRS
Age Pediatric and adult Pediatric, adult, older adult Pediatric and adult Adult Adult; pediatric measure in development
Available Languages >40 (including English and Spanish) English and Spanish English and Spanish English and Spanish English, Spanish, German, and Japanese
Others in development Others in development Others in development Others in development Others in development
Contexts of Use Population surveillance, clinical research and trials, care delivery Epidemiologic studies, clinical research and trials Population surveillance, clinical research and trials in persons with a neurologic disorder Population surveillance, clinical research and trials in persons with Sickle Cell Disease Cancer clinical trials including supportive care trials, clinical studies of cancer patients and survivors
For more information www.HealthMeasures.net www.HealthMeasures.net www.HealthMeasures.net www.HealthMeasures.net http://healthcaredelivery.cancer.gov/pro-ctcae/